Literature DB >> 2877340

Colestipol plus fenofibrate versus synvinolin in familial hypercholesterolaemia.

P Weisweiler, P Schwandt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2877340     DOI： 10.1016/s0140-6736(86)92214-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Clinical implications of new drugs for lowering plasma cholesterol concentrations.

Authors:  D R Illingworth
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

Review 2.  Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia.

Authors:  J A Balfour; D McTavish; R C Heel
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 3.  Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

4.  Simvastatin and bezafibrate: effects on serum lipoproteins and lecithin: cholesterol acyltransferase activity in familial hypercholesterolaemia.

Authors:  P Weisweiler
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.